Clivatuzumab Biosimilar - Anti-CD227,MUC1 mAb - Research Grade, Human Humanized, Monoclonal
Artikelnummer:
PTG-PX-TA1390-1MG
- Bilder (0)
| Artikelname: | Clivatuzumab Biosimilar - Anti-CD227,MUC1 mAb - Research Grade, Human Humanized, Monoclonal |
| Artikelnummer: | PTG-PX-TA1390-1MG |
| Hersteller Artikelnummer: | PX-TA1390-1MG |
| Alternativnummer: | PTG-PX-TA1390-1MG |
| Hersteller: | ProteoGenix |
| Wirt: | Human Humanized |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | Anti-CD227, Anti-MUC1, Anti-CA15-3, IMMU-107, hPAM4, hPAM4 IgG-DOTA, hPAM4-DOTA, CAS: 1622075-09-5 |
| Klonalität: | Monoclonal |
| UniProt: | P15941 |
| Puffer: | 0.01M PBS, pH 7.4. |
| Expression System: | Eukaryotic expression |
| Target-Kategorie: | CD227/MUC1 |
Produktgarantie und fachkundiger Support
